butabarbital will decrease the extent or result of doravirine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.butabarbital will lessen the extent or outcome of levamlodipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism.butabarbital will lower the level or influence of cannabidiol by impacting hepatic/intestinal